European GMP Regulations: Ongoing Changes and What Lies Ahead

18.05.2026

LOGFILE Feature

Report from the 2026 ISPE European Annual Conference, 20-22 April 2026, Copenhagen

4 min. reading time | by Sabine Paris, PhD
Published in LOGFILE 10/2026

At the 2026 ISPE European Annual Conference in Copenhagen, Brendan Cuddy (EMA) provided a concise update on current European GMP regulatory developments and the work of the GMP/GDP Inspectors Working Group (GMDP IWG).

A clear message emerged: stakeholders strongly support the regulators’ direction of travel toward modernising EU GMP guidance. Significant numbers of comments were received during consultations – particularly for Chapter 4, Annex 11, and the new Annex 22 on AI.

Current Status of Key Documents

Publication is expected shortly:

Annex 19 (Reference and Retention Samples), update following the separation of veterinary GMP requirements in the new Implementing Regulations

Review of comments completed:

Chapter 4 (Documentation)
Annex 22 (Artificial Intelligence)
Part IV (ATMPs)

Review of comments ongoing:

Chapter 1 (Pharmaceutical Quality System):
Comment review has started.

Annex 11 (Computerised Systems):
The drafting group has already classified around 2,900 comments, with detailed review work now to follow. Finalisation of the review is expected over the summer.

Annex 3 (Radiopharmaceuticals):
Comment review is ongoing.

Annex 6 (Medicinal Gases) and Annex 15 (Qualification and Validation):
Consultations on the concept papers have recently closed. Review of comments is the next step.

Drafting is expected shortly:

Annex 14 (Plasma derived Medicines):
Update due to the SoHo Regulation 2024/1938 on substances of human origin

Supplementary Guidance planned for 2026:

Q&As on contamination control for non-sterile manufacturing
Q&As on decentralised manufacturing

Figure 1 | Current status of draft guidelines (Brendan Cuddy, 2026 ISPE European Annual Conference)

Annex 22 on Artificial Intelligence (AI): A Key Debate

One of the most significant themes raised in consultation was that the guidance should not categorically prohibit specific technologies such as Large Language Models (LLMs). Instead, many stakeholders support a risk-based approach, focusing on GMP criticality, intended use, controls, and oversight.

In response, EMA plans to hold an online expert workshop with stakeholder associations at the end of June 2026 to explore whether a risk-based framework, supported by appropriate guardrails, can adequately address the opportunities and risks of Generative AI in GMP environments.

Modernisation of EudraGMDP

Brendan pointed out that the objective is to improve performance of the data base, deliver user-focused capabilities, and transition to a modern platform.

A new user interface will allow a single global search across all types of documents.

User Acceptance Testing (UAT) for manufacturing authorisations and GMP certificates is planned for Q3 2026. UAT for the registration of APIs, wholesaler distribution authorisations and GDP is planned for Q4 2026.

GDP

An EU/EEA GDP Working Group has been established to work on:

a new procedure for dealing with serious non-compliance with GDP
a revision of the GDP inspection procedure to formalise the risk-based approach to GDP inspection planning
new guidance for wholesalers on performing risk assessment for the verification of the authenticity of medicinal products at risk of falsification

Do you have any questions or suggestions? Please contact us at: redaktion@gmp-verlag.de

Dr. Sabine Paris Published on 18 May 2026

You may also be interested in the following articles:

Applying the FDA’s 7-Step Model for AI/ML Validation in GMP Environments: One Year Later

07.09.2026

LOGFILE Feature

Applying the FDA’s 7-Step Model for AI/ML Validation in GMP Environments: One Year Later

Artificial intelligence is becoming increasingly important in GMP-regulated environments, presenting companies with new regulatory challenges. This article summarizes the latest regulatory developments, introduces a validation framework based on the FDA's seven-step model, and outlines initial practical experience with AI/ML validation.

07.09.2026

Question of the Week

What are the General Requirements for Standard Documents?

Here's the answer:

04.09.2026

News

EDQM: Revised Guidance on Sister File Applications

The European Directorate for the Quality of Medicines & HealthCare (EDQM) has revised its Guidance on applications for “sister files” (PA/PH/CEP (09) 141). The revision is intended to support consistent application of the procedure and provide greater clarity on the classification and assessment of the corresponding CEP applications.

Swissmedic Clarifies Requirements for QR Codes on Medicinal Product Packaging

04.09.2026

News

Swissmedic Clarifies Requirements for QR Codes on Medicinal Product Packaging

Swissmedic has revised its guidance document “Mobile technologies” and added two new entries to the related questions and answers. The update follows an increasing number of queries regarding the details and placement of URLs, the positioning of QR codes and their captions.

28.08.2026

News

EMA: Withdrawal of an Application due to Missing Confirmation of a Manufacturing Site’s GMP Status

EMA reported that Scholar Rock Netherlands withdrew its application for Isembyld after evaluation had progressed through the final round of questions. EMA’s provisional view was that the medicine could not be authorised because the applicant had not provided confirmation that the manufacturing site complied with EU GMP requirements.

28.08.2026

News

France: ANSM Launches Pilot Project to Extend the Shelf Life of Medicines

The French medicines agency ANSM has published an update on its “Longue vie aux médicaments” pilot project aimed at extending the shelf life of medicines. Fourteen pharmaceutical companies responded to the call for applications. The project covers a total of 73 medicines, including commonly used products containing paracetamol, levothyroxine, melatonin or lithium.

Related Products

GMP Compliance Adviser | Named User Licence | 12M

The GMP Compliance Adviser is an online publication that covers all aspects of Good Manufacturing Practice (GMP) in one source.In the GMP Compliance Adviser you’ll find: GMP in Practice This part contains 21 chapters with GMP expert knowledge to base your decisions upon. It provides practical assistance with checklists, templates and SOP examples. It is written by more than 80 authors with hands-on experience directly linked to the industry. The individual chapters describe the different aspects of GMP in clear language. Technical, organizational and procedural aspects are covered.More than 700 checklists, templates and examples of standard operation procedures taken directly out of practice help you in understanding the GMP requirements.GMP RegulationsThese chapters cover the most important GMP regulations from Europe and the United States (CFR and FDA), but also PIC/S, ICH, WHO and many more. Sample Documents In addition, the GMP Compliance Adviser contains many sample documents and practical examples that you can use.

delivery time appr. 2-5 workdays after receipt of payment

€1,368.00 net excl. VAT

Details

GMP:KnowHow Pharma Logistics (GDP) | Named User Licence | 12M

Your knowledge portal for GDP-compliant pharmaceutical logistics. It is important that you as a logistics service provider, but also as a client in the pharmaceutical industry, comply with regulatory requirements. The GMP:KnowHow knowledge portal guides you through the complex regulatory landscape of the pharmaceutical and logistical supply chain! The knowledge portal gives you an easy-to-understand overview of all the important topics. Interactive graphics help you navigate all areas covered by the EU GDP Guidelines (2013/C 343/01). You also have the relevant passages of the regulations directly at hand for each topic. This allows you to compare the requirements directly and saves valuable research time.One thing is certain: the knowledge portal answers your questions about the supply chain of medicinal products, active pharmaceutical ingredients and medical devices. You don't have to be an expert. Yet.You will find answers to your questions in the GMP:KnowHow Pharma Logistics (GDP). Where does GDP begin, where does GMP end? What does GDP-compliant mean? When do I also have to take GMP requirements into account? What permits do I need for certain activities? What requirements do I have to fulfil? What is the current legal basis? How am I covered? What authorizations do I have for my work, e.g. from my employer? Who is responsible — the client or the contractor? And many more What is the difference to the GMP Compliance Adviser? GMP:KnowHow Pharma Logistics (GDP) is a practical knowledge portal dedicated to Good Distribution Practice (GDP). It is a product that is independent of the GMP Compliance Adviser and concentrates on content that is essential for carriers of medicinal products, active pharmaceutical ingredients and medical devices as well as for logistics clients. The focus is on practical knowledge and how to apply it in your daily business. If necessary, the relevant regulations can be called up immediately alongside the practical knowledge, and you can see the relevant paragraphs at a glance. In addition, sample documents are available to help you make immediate progress. AuthorSimone Ferrante, currently Director Quality at Fisher Clinical Services, previously served as Head of Quality Control and Responsible Person (GDP) for the Grieshaber Group. She is also a long-standing author and GDP expert at GMP-Verlag.

delivery time appr. 2-5 workdays after receipt of payment

€610.00 net excl. VAT

Details

E-Learning GMP:READY | Specialist Knowledge GMP for Engineers

Why are GMP rules important for technicians and engineers? Technicians and engineers play a key role in ensuring compliance with Good Manufacturing Practice (GMP) standards. They are involved in critical activities such as: planning and construction of ventilation systems, maintenance of water treatment plants, calibration of measuring sensors. Therefore, they are jointly responsible for the quality of medicines and must ensure that their work complies with GMP standards.Your advantages: Fast familiarization with GMP topics in approx. 2 hours, time- and location-independent online training, printable personal certificate, 12-month access for initial and follow-up training, automatic updates in case of legal changes,content compliant with Article 7(4) of Directive 2003/94/EC.The Author This e-learning course was developed with the collaboration of Dipl.-Ing. Andreas Nuhn (D & B Pharmadesign GmbH).

delivery time appr. 2-5 workdays after receipt of payment

€245.00 net excl. VAT

Details

GMP Fundamentals | A Step-by-Step Guide

This handbook is a practical and easy to read guideline, giving you a quick and comprehensive overview of the complex world of Good Manufacturing Practice (GMP) without the need of previously acquired knowledge. Some topics are: GMP: Purpose and basic pharmaceutical terms Laws, licenses and inspections Personnel: Responsibility and hygiene Standard Operating Procedures (SOP) and documentation Design of rooms and facilities Processing and packaging Quality control and market release Suppliers, storage and logistics (Good Distribution Practice = GDP) Alphabetical index and abbreviations Using practical examples and comparisons to every-day life will help to easy understand GMP regulations.GMP Fundamentals is a helpful guide which facilitates the entry into the GMP world and teaches the necessary basics.

delivery immediately after receipt of payment

€44.90 net excl. VAT

Details